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ING2 is a candidate tumor suppressor gene that can activate p53 by enhancing its acetylation. Here, we
demonstrate that ING2 is also involved in p53-mediated replicative senescence. ING2 protein expression
increased in late-passage human primary cells, and it colocalizes with serine 15-phosphorylated p53. ING2 and
p53 also complexed with the histone acetyltransferase p300. ING2 enhanced the interaction between p53 and
p300 and acted as a cofactor for p300-mediated p53 acetylation. The level of ING2 expression directly
modulated the onset of replicative senescence. While overexpression of ING2 induced senescence in young
fibroblasts in a p53-dependent manner, expression of ING2 small interfering RNA delayed the onset of
senescence. Hence, ING2 can act as a cofactor of p300 for p53 acetylation and thereby plays a positive
regulatory role during p53-mediated replicative senescence.
Cellular senescence, a process originally described by Hay-
flick in 1965 (28), prevents normal human fibroblasts from
growing indefinitely in culture. This process, also termed rep-
licative senescence, is driven by telomere attrition. The expres-
sion of telomerase, which maintains the telomere length, pre-
vents cells from undergoing replicative senescence (6, 27).
Stimuli having little or no impact on telomeres have also been
shown to induce growth arrest with a senescence-like pheno-
type (generally called stress-induced senescence or premature
senescence). These stimuli include DNA damage, chromatin
remodeling, strong mitogenic signals, or suboptimal cell cul-
ture conditions. Thus, oncogenic ras can also induce senes-
cence in cells, and promyelocytic leukemia protein (PML) has
been shown to be essential for the induction of ras-induced
senescence (17, 41).
Cells need to bypass senescence to become transformed
(46). Consistent with its role in suppressing cancer develop-
ment, senescence is controlled by two major tumor suppres-
sors, the p53 gene and the retinoblastoma gene (Rb) (5, 37).
An increase in p53 transcriptional activity is a molecular sig-
nature for cellular senescence (3, 7, 50). The increased activity
is driven by changes in p53 phosphorylation and acetylation
status (41, 53).
The DNA damage sensor proteins ATM, Chk1, and Chk2
are recruited to the site of shortened telomeres in senescent
cells (4, 13, 21, 29, 43, 48). Interestingly, p53 is also phosphor-
ylated and thus activated by all the above-mentioned kinases
(10), and p53 phosphorylation is a signal for subsequent acet-
ylation (15, 33). p53 acetylation, which is required for its full
activity, increases in both replicative and ras-induced senes-
cence (41). During ras-induced senescence, PML is required
for p53 acetylation by CBP in nuclear bodies (17, 41).
The ING family proteins are candidate tumor suppressors
that associate with histone acetyltransferase (HAT), histone
deacetylase, and factor acetyltransferase complexes (16). All
the ING genes share a PHD finger motif, which may be impli-
cated in chromatin-mediated transcriptional regulation (1, 40).
In tumors, ING genes are not frequently mutated, but expres-
sion is down-regulated in several tumor types, including breast,
blood, esophageal, lung, brain, bladder, stomach, and liver
cancer (16, 19, 39, 49). Five members of the ING family have
been identified in humans. ING1 to ING5 cooperate with the
p53 tumor suppressor protein to induce cell growth arrest and
apoptosis (18, 35, 36, 47). ING1, ING2, ING4, and ING5 can
regulate p53 by enhancing its acetylation on lysine residues 373
or 382 (32, 35, 47). There are multiple mechanisms by which
ING genes may modulate p53 acetylation. For example,
p33ING1b (one of the three alternative splice variants of
ING1) binds to SIRT1 and inhibits its deacetylation activity on
p53, resulting in an increase in the level of active, acetylated
p53 (32). p33ING1b, ING4, and ING5 can physically interact
with the p300 protein and could thereby modulate HAT activ-
ity (47, 51). Finally, ING2 is not only critical to enhance p53
acetylation on lysine 382, but it is also up-regulated in response
to etoposide and neocarzinostatin. In cells with down-regu-
lated ING2, p53 acetylation, p21 expression, and apoptosis are
reduced following etoposide treatment (23, 35).
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In this study, we investigated the functional role of ING2 in
replicative senescence. We demonstrate that ING2 and serine
15-phosphorylated p53 (hereafter termed phospho-p53
[Ser15]) protein expression is elevated during replicative se-
nescence in human fibroblasts. Under these conditions, ING2
and phospho-p53 (Ser15) colocalize (i.e., assemble at distinct
nuclear foci) and physically interact with p300. This complex is
located outside PML nuclear bodies. Mechanistically, ING2
physically interacts with p300 in vitro and in vivo and enhances
p300-mediated p53 acetylation in vitro. ING2 also regulates
the onset of replicative senescence: the overexpression of
ING2 in young fibroblasts induces premature senescence in a
p53-dependent manner, and down-regulation of ING2 de-
creases p53 acetylation and delays the onset of replicative
senescence. We propose that ING2 plays a major role in reg-
ulating the p53-dependent senescence checkpoint.
MATERIALS AND METHODS
Cell culture, transfection, retroviral gene transfer, and SA--Gal assays.
MRC5 fibroblasts, Amphopack 293 (BD Biosciences Clontech), and U2OS cells
were grown in standard cell culture medium at 37°C. Cells were transfected with
Lipofectamine Plus reagent (Invitrogen) according to the manufacturer’s instruc-
tions. For fibroblast infection, the packaging cell line Amphopack 293 was trans-
fected for 3 h. Thirty hours after transfection, the medium containing the virus
was recovered and filtered with 0.45-m low-binding protein filters (Pall Corpo-
ration, MI). The media containing the viral particles was used to infect the
fibroblasts for 8 h in the presence of hexadimethrine bromide (Sigma) at 8 g/ml.
The medium was subsequently replaced with fresh medium, and cells were
allowed to grow for 24 h. MRC5 cells were selected with G418 (800 g/ml;
Invitrogen) or Puromycine (1 g/ml; Sigma) for 5 to 7 days. Selection was
continued until all mock-infected cells were dead; subsequently, the cells were
grown in medium without any selection. Senescence-associated -galactosidase
(SA--Gal) activity was detected in fibroblasts as previously described (14, 45).
Plasmids and primers. (i) Plasmids. ING2 was cloned in pCLXSN (38) vector
and pFLAG-CMV-6c vector (Sigma). p53 interfering RNA (RNAi), ING2
RNAi, and control RNAi were all cloned in pSuperRetro (Oligoengine). The
respective sequences have all been previously described (12, 23). A previously
described retrovirus vector, pBabe-Puro ras (H-RasV12) (45), was used to induce
senescence. For reverse transcription-PCR (RT-PCR), the sequences of the
primers used were CGAGATCCCTCCAAAATCAA and ATCCACAGTCTTC
TGGGTGG for gapdh and AAAATCGGGCAAGACAAATG and GAAGCT
TCCCTTTCCTGCTT for ING2.
(ii) Antibodies. The following antibodies were used: for anti-p53, monoclonal
antibodies DO-1 and 1801 (Santa Cruz) and polyclonal antibody CM1 (Signet
Laboratories); for anti-phospho-p53 (Ser15), rabbit polyclonal and monoclonal
16G8 (Cell Signaling); for anti-acetyl-p53 (Lys382), polyclonal (Oncogene Re-
search); for anti-ING2, goat polyclonal ab2643 (Abcam) and rabbit polyclonal
Ping2 (35); for anti-p300, rabbit polyclonal N15 (Santa Cruz) and monoclonal
RW128 (Upstate); for anti-PML, monoclonal PGM-3 (Santa Cruz); for anti-
Flag, monoclonal M2 (Sigma); for anti--actin, mouse monoclonal AC-15
(Sigma). Secondary antibodies were purchased from Jackson Laboratories,
Southern Biotechnology Associates, and Santa Cruz.
Western blot analysis. Subconfluent cultures of cells were harvested and lysed
in a buffer containing 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, 400 mM NaCl,
10% glycerol, 0.5% NP-40, 5 mM NaF, 0.5 mM sodium orthovanadate, 1 mM
dithiothreitol (DTT), and protease inhibitor cocktail (Roche). Equal amounts of
cell lysates (20 g) were resuspended in 2 Tris-glycine sodium dodecyl sulfate
(SDS) sample buffer, electrophoresed on 10% SDS-polyacrylamide gels, and
electrophoretically transferred to Immobilon-P membranes (Millipore).
Immunoprecipitation. Whole-cell lysates were prepared from MRC5 cells or
transfected U2OS cells, using previously described immunoprecipitation buffers
and conditions (44). For each immunoprecipitation, 2 g of the antibody was
incubated with 1 mg of the lysate for 1 h. After being washed, the samples were
analyzed by Western blotting for detection of the coimmunoprecipitated pro-
teins.
Immunofluorescence. Cells were grown on glass slides for 48 h (to minimize
stress that may arise during passaging), treated with a hypotonic lysis buffer, and
fixed in 100% cold ethanol. The entire immunofluorescence protocol was carried
out as previously described (44). The slides were visualized with a Zeiss Axioskop
fluorescence microscope equipped with a high-performance charge-coupled de-
vice imaging system (IP Lab spectrum). Confocal fluorescent images were col-
lected with a Bio-Rad MRC 1024 confocal scan head mounted on a Nikon
Optishot microscope with a 60 objective. Sequential excitation at 488 nm, 568
nm, and 647 nm was provided by a krypton-argon gas laser. Emission filters of
522/32, 598/40, and 680/32 were used for collecting green, red, and far-red
fluorescence in channels one, two, and three, respectively. After sequential
excitation, green, red, and far-red fluorescent images of the same cell were saved
with Laser Sharp software. Images were analyzed with both Bio-Rad and Zeiss
software. The term colocalization refers to the coincidence of green and red
fluorescence, as measured by the confocal microscope. Colocalization in quan-
tification graphs indicates the percentage of the proteins that colocalize with
each other as measured with the Bio-Rad and/or Zeiss software. At least 100
cells were analyzed for each colocalization experiment, and typically five to ten
cells per experiment were quantified using the Bio-Rad LaserSharp software.
Statistical analysis with the software determined the Pearson’s correlation (PC),
which compares the colocalization of two different types of fluorescence and
their intensity; the higher the fluorescence intensities are at the site of colocal-
ization, the higher the PC will be, with a maximum of 1. The experiments were
repeated at least twice.
Expression and purification of ING2 protein. ING2 was cloned in the pFAST-
BAC plasmid (Invitrogen). Recombinant pFASTBAC plasmid was used to trans-
form competent DH10BAC cells for transposition to the bacmid shuttle vector.
Bacmid recombinants were identified by LacZ selection on X-Gal (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside) and IPTG (isopropyl--D-thiogalacto-
pyranoside) plates, and composite bacmid DNA was isolated from selected
colonies. Cellfectin (Invitrogen) was used to transfect recombinant DNA in
monolayers of Sf9 insect cells. Viral supernatant was harvested after 4 days and
used for further infections. To produce ING2protein, Sf9 cells growing in sus-
pension were infected with the virus (multiplicity of infection, 3) and harvested
72 h after infection. ING2 protein was purified with Probond resin (ProBond
Purification System, Invitrogen), under native conditions as recommended by the
manufacturer. The protein was dialyzed twice at 4°C for at least 6 h in a Tris
buffer (20 mM Tris-HCl, pH 7.9, 100 mM NaCl, 20 M ZnCl2, 1 mM DTT, and
25% glycerol). The ING2 recombinant protein was 90% homogenous as as-
sessed by Coomassie blue staining.
In vitro p53 acetylation. Assays were performed in buffer A (50 mM Tris-HCl
[pH 8.0], 10% glycerol, 1 mM DTT, 0.1 mM EDTA, 10 mM sodium butyrate).
The amounts of purified proteins used for assays were as follows: p53, 1 g; p300,
5 to 20 ng; and ING2, 5 to 40 ng. Baculovirus-purified p300 and p53 proteins
were purchased from Proteinone (College Park, MD). Glutathione S-trans-
ferase–p53 protein was purchased from Santa Cruz. Substrate concentrations
were 0.1 to 0.2 mg/ml for [1-14C]acetyl coenzyme A ([1-14C]acetyl-CoA) (Am-
ersham) or 10 M for cold acetyl-CoA (Sigma). Assays were incubated at 30°C
for 30 min and initiated by addition of the protein substrate (p53) to a mixture
containing p300 and acetyl-CoA in buffer A. The incorporation of [1-14C]acetyl-
CoA was quantified after SDS-polyacrylamide gel electrophoresis with a Phos-
phorImager (Fuji). Cold acetylation was detected by using the anti-acetyl-p53
(Lys382) antibody, and the signal intensity was determined using Aida software.
RESULTS
ING2 expression during replicative and premature senes-
cence. ING1 has been previously shown to play a role in rep-
licative senescence (20). In addition, p53 acetylation on lysine
382 increases during replicative senescence (41), and acetyla-
tion enhancement on this residue can be mediated by ING2
(35). Therefore, we investigated the involvement of ING2 in
p53-mediated replicative senescence. We carried out the stud-
ies with young primary MRC5 fibroblasts at a population-
doubling value of 28 (PDL28) and senescent fibroblasts at
PDL63 (Fig. 1A and B). The p53 profile of expression was
similar to what has been previously reported with no marked
increase in the p53 protein expression (3, 7, 53). However, in
contrast to the PDL28 fibroblasts, the p53 protein was tran-
scriptionally active in PDL63 MRC5 cells, leading to the in-
duction of p21WAF1/SDI1 (hereafter referred as p21) (Fig. 1C
and D).
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To determine whether ING2 mRNA and protein expression
was altered during senescence, we carried out RT-PCR and
Western blot analysis of PDL28 and PDL63 fibroblast lysates.
While the ING2 mRNA level remained unchanged (Fig. 1E),
ING2 protein level was four- to sixfold higher in senescent
fibroblasts (Fig. 1F). A similar increase of ING2 expression
was also observed with senescent WI38 human fibroblasts
when compared with young fibroblasts (data not shown). ING2
was localized in detergent nonextractable nuclear foci in both
young and senescent fibroblasts. In contrast to Western anal-
ysis of total ING2 content, prelysis of the cells prior to fixation
allowed the elimination of most of the soluble proteins and
detection of mainly insoluble proteins. Both the intensity and
the extent of the focal accumulation of ING2 increased in
senescent cells (Fig. 1G).
To determine whether the enhanced ING2 expression was
specific for replicative senescence, we induced premature se-
nescence in PDL28 fibroblasts with a ras-expressing retrovirus.
Premature senescence was observed in at least 50% of the
FIG. 1. Expression of ING2 in normal young (PDL28) and repli-
cative senescent (PDL63) MRC5 human fibroblasts. Typically, senes-
cent cells were larger, with larger nuclei and a decreased density of
confluence. More than 90% of the senescent cells were positive by the
SA--Gal assay, whereas with PDL28 fibroblasts, very few cells were
positive. Though the amount of detectable p53 was similar between
PDL28 and PDL63, a strong increase in p21WAF1/SDI1 mRNA and
protein was observed in the senescent fibroblasts, thereby indicating
the presence of transcriptionally active p53. Other known p53 target
genes were also transcriptionally activated, e.g., WIG1 and PERP
(data not shown). (A and B) Replicative senescence induced SA--Gal
expression. MRC fibroblasts at PDL28 and PDL63 were stained for
SA--Gal expression (A) and quantitated (B). The graphs represent
means  standard deviation (SD). (C and D) p53 and p21WAF1/SDI1
protein expression during replicative senescence. Lysates (C) or
mRNA (D) was analyzed for the expression of p53 and p21WAF1/SDI1
(for protein in panel C) or only p21WAF1/SDI1 (for mRNA in panel D).
-Actin and gapdh expression were used as controls in the experiments
shown in panels C and D, respectively. (E) ING2 mRNA expression is
unaltered in young and replicative senescent fibroblasts. RNA was
extracted from young and senescent fibroblasts. RT-PCR was carried
out with specific primers against gapdh or ING2 primers. (F) ING2
protein expression increases during replicative senescence. Cell ex-
tracts from young and senescent fibroblasts were subjected to Western
blotting and probed with ING2 (rabbit) or -actin antibody. (G) ING2
immunofluorescence increased during replicative senescence. Cells
from young and senescent fibroblasts were subjected to immunofluo-
rescence with ING2 (goat) antibodies. Nuclei were typically larger in
senescent cells.
FIG. 2. ING2 is not involved in ras-induced and PML-mediated
senescence. (A) ras-induced senescence showed the expression of SA-
-Gal. SA--Gal was assayed in young MRC5 fibroblasts infected with
an empty (control) or ras-containing retrovirus. (B) Quantification of
the percentage of cells positive for SA--Gal staining. The graphs
represent means  SD. At least 300 cells were counted from the
experiment shown in panel A. (C) ING2 protein expression in ras-
induced senescent fibroblasts. Extracts were prepared from cells in-
fected with empty (control) or ras-containing retrovirus and Western
blotted with antibodies against ING2, p21WAF1/SDI1, p16, and -actin.
(D) ras-induced senescence in MRC5 fibroblasts in which ING2 was
knocked down. Quantification of the percentage of cells positive for
the SA--Gal staining was performed; the graphs represent means 
SD. At least 300 cells were counted. (Top) Western blot detection of
ING2 (rabbit) and -actin in MRC5 fibroblasts containing scrambled
or ING2 siRNA retroviral constructs. (E) Immunofluorescence detec-
tion of ING2 and PML in young and senescent fibroblasts. Cells from
young and senescent fibroblasts were subjected to immunofluores-
cence with ING2 (goat)/PML antibodies. (F) Quantification of PML/
ING2 colocalization. The graphs represent means  SD. Statistical
significance of the colocalization was performed using PC.
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cells, as detectable by an SA--Gal assay (Fig. 2A and B). In
contrast to late-passage fibroblasts, ING2 protein levels de-
creased during ras-induced senescence (Fig. 2C), while the
amount of p21 and p16 protein increased. Furthermore, ras
induced premature senescence in fibroblasts in which ING2
was knocked down (Fig. 2D). These data indicate that ING2
may not play a significant role in ras-induced senescence.
PML plays a pivotal role in ras-induced senescence and may
also play a role in replicative senescence (17, 41). To determine
whether the role of ING2 in replicative senescence could also
be mediated via PML, we examined ING2/PML immunocolo-
calization in PDL28 and PDL63 fibroblasts. We did not ob-
serve any statistically significant differences in the probability
(as designated by PC) or the percentage of colocalization be-
tween ING2 and PML in young and senescent fibroblasts (Fig.
2E and F). These results indicate that ING2 may have a unique
role in replicative senescence, which is likely to be independent
of PML.
ING2 colocalizes with posttranslationally modified p53. p53
transcriptional activity is regulated by ING2 (35), which in-
creased during replicative senescence (Fig. 1); therefore, we
investigated the relationship between ING2 and p53 in late-
passage versus early-passage cells. First, we wanted to deter-
mine whether p53 and ING2 could physically interact (directly
or as part of a complex) and colocalize, especially in senescent
fibroblasts. The level of total p53 did not change between
PDL28 and PDL63 when tested with different anti-p53 anti-
bodies (Fig. 1D and 3F). However, p53 (detected by the C-
FIG. 3. ING2 and translationally modified p53 colocalize in replicative senescent fibroblasts. (A) ING2 colocalized with p53 in both young and
senescent fibroblasts. Immunofluorescence was carried out in young and senescent fibroblasts with antibodies against ING2 (goat) and p53 (CM1).
(B) Quantification of ING2/p53 (CM1) colocalization. The graphs represent means  SD. Statistical significance of the colocalization was
performed using PC. (C) ING2 colocalized with p53(Ser15) in senescent fibroblasts. The experiment was the same as that shown in panel A, except
that immunofluorescence was done with ING2 (goat)/p53 (Ser15) (rabbit) antibodies. (D) Quantification of ING2/p53 (Ser15) colocalization. The
graphs represent means  SD. Statistical significance of the colocalization was performed using PC. (E) Colocalization pattern of ING2 and p53
(Lys382). The experiment was the same as that shown in panel A, except that immunofluorescence was done with ING2 (goat)/p53 (Lys382)
antibodies. (F) Expression of posttranslationally modified p53 in young and senescent fibroblasts. Extracts from young and senescent fibroblasts
were subjected to Western blotting and probed with antibodies against p53 (Ser15), p53 (CM1), and -actin antibodies. For the detection of
acetylated p53, p53 was immunoprecipitated with DO-1 and 1801 antibodies in young or senescent fibroblasts, and probed with p53 (Lys382)
antibodies. The amount of p53 protein immunoprecipitated was detected with p53 (DO-1).
6642 PEDEUX ET AL. MOL. CELL. BIOL.
 o
n
 August 29, 2017 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
terminal-specific antibody CM1) partly colocalized with ING2
(Fig. 3A), and we observed an increase in colocalization during
senescence that was statistically significant (Fig. 3B).
p53 is phosphorylated at serine 15 and acetylated at lysine
382 during replicative senescence (29, 41, 53). We observed
that the protein level of p53-serine 15 phosphorylation and
p53-lysine 382 acetylation increased in PDL63 fibroblasts (Fig.
3F). However, while the colocalization of ING2 with p53
(Ser15) was dramatically enhanced in senescent fibroblasts
(Fig. 3C and D), we reproducibly detected a drastic decrease in
the number of foci containing p53 lysine 382 during senescence
(Fig. 3E). We hypothesized that the p53-lysine 382 epitope
could be masked by a protein complex during senescence,
which prevented its subsequent detection by immunofluores-
cence. To determine whether such masking of the p53-lysine
382 epitope was also possible in young fibroblasts, we treated
FIG. 4. ING2 and p300 colocalizes and may form a triple complex with p53. (A) ING2 protein and p300 colocalized in young and senescent
fibroblasts. Immunofluorescence was carried out in young and senescent fibroblasts with antibodies against ING2 (goat) and p300 (N15).
(B) Quantification of ING2/p300 colocalization. The graphs represent means  SD. Statistical significance of the colocalization was performed
using PC. (C) Levels of p300 in young and senescent fibroblasts. Lysates were made from young and senescent fibroblasts, Western blotted, and
probed with antibodies against p300 (N15) and -actin antibodies. (D) ING2, p300, and p53 (Ser15) colocalized together in senescent fibroblasts.
The experiment was the same as that shown in panel A, except that immunofluorescence was done with antibodies against ING2 (goat), p300
(N15)/p53 (Ser15) (rabbit) antibodies. White foci represent triple colocalization. (E) ING2, p53 (Ser15), and p300 may form a triple complex in
senescent fibroblasts. The experiment was the same as that shown in panel C, except that lysates were immunoprecipitated with p300 (N15)
antibody. The immunoprecipitates were self probed with antibodies against p300 (N15) antibody. Coprecipitating proteins were detected with
antibodies against p53 (Ser15) (16G8) and ING2 (rabbit). Lysates used were the same as in panel C and Fig. 1B and 3F. (F) ING2 enhances the
complex between p53 and p300. U2OS cells were transfected with a Flag-ING2 expression vector. Lysates were immunoprecipitated with
antibodies against p53 (DO-1 and 1801) or p300 (N15), and immunoprecipitation was verified with self antibody p53 (DO-1) or p300 (RW128).
Coimmunoprecipitated proteins were detected with antibodies against p53 (DO-1) and Flag (M2) antibodies. A total of 5% of the amount of
whole-cell lysates used for immunoprecipitation was probed with p300 (RW128), p53 (DO-1), Flag (M2), and -actin antibody.
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PDL28 fibroblasts with etoposide and adriamycin. As reported
earlier (35), etoposide treatment increases the ING2 protein
level. However, lysine 382-acetylated p53 was not observed by
immunofluorescence in cells treated with etoposide (see Fig.
S1A and S1B in the supplemental material), thereby indicating
that masking of p53-lysine 382 was possible under certain con-
ditions when both p53 and ING2 were stabilized. Overall,
these results demonstrate that ING2 colocalized with, at the
very least, serine 15-phosphorylated p53 during replicative se-
nescence, suggesting that ING2 functions in complexes con-
taining activated, modified p53 molecules.
Serine 15-phosphorylated p53 and ING2 complex with p300
in senescent fibroblasts. The acetylation of p53 occurs during
senescence (41); therefore, we wanted to examine whether the
ING2/p53 complex has any physical or functional interactions
with two members of the HAT family, p300 and CBP, both
known to acetylate p53 on lysine 382 (26). The level of CBP
was the same in PDL28 and PDL63 (see Fig. S2C in the
supplemental material). ING2 and CBP foci did not show any
appreciable colocalization in either the young or senescent
fibroblasts (see Fig. S2A and S2B in the supplemental mate-
rial). The total amount of cellular p300 protein level, detected
with three antibodies (N15, C20, and RW128), decreased in
senescent fibroblasts (Fig. 2C and data not shown). A similar
decrease in p300 levels has also been observed after UV irra-
diation (54). With the same antibodies, numerous endogenous
p300 foci were detected by immunofluorescence. These deter-
gent nonextractable foci possibly accounted for the chromatin-
bound p300 and remained at approximately equal levels in
both young and senescent fibroblasts. More significantly, the
p300 foci showed a small but statistically significant colocaliza-
tion with ING2 in both young and senescent fibroblasts (Fig.
4A and B) with the PC for ING2/p300 colocalization increased
by 50% in senescent cells.
To determine whether the ING2/p300 colocalization and
serine 15-phosphorylated p53/ING2 colocalization might be
one and the same, triple colocalization was performed. Indeed,
with PDL63 cells, ING2, p300, and p53-serine 15 colocalized
extensively with each other, as visualized by white foci (Fig.
4D). The extremely low level of serine 15-phosphorylated p53
in young fibroblasts may have prevented its detection or colo-
calization with the ING2/p300 complex in young fibroblasts.
Moreover, immunoprecipitation of lysates from early- and
late-passage cells with the p300 antibody indicated that p300
physically interacted with ING2 and p53, preferably in senes-
cent cells (Fig. 4E). The complex formation between p53,
ING2, and p300 was further corroborated in transient trans-
fections in wild-type p53-containing U2OS cells, where immu-
noprecipitation of endogenous p300 also contained p53 and
transfected Flag-ING2 (Fig. 4F). More p53 was detected with
immunoprecipitated p300 when ING2 was also cotransfected,
thereby indicating that ING2 may enhance the interaction be-
tween p53 and p300. Furthermore, immunoprecipitation of
endogenous p53 contained transfected Flag-ING2. Collec-
tively, these results indicate that ING2, p300, and serine 15-
phosphorylated p53 are complexed together preferentially dur-
ing replicative senescence in human cells.
ING2 increases p300-mediated p53 acetylation in vitro. The
above results, which indicate that ING2 may enhance colocal-
ization and physical interaction between p53 and p300 in se-
nescent cells, led us to examine whether ING2 can increase in
vitro p300-dependent p53 acetylation. As previously reported
(26), increasing amounts of p300 progressively enhanced p53
acetylation, as detected either by an acetylation-specific p53
antibody (Fig. 5A) or by the incorporation of 14C-acetyl-CoA
into p53 (Fig. 5B). With a constant amount of p300, increasing
the amounts of purified ING2 protein led to a further two- to
fourfold increase in the acetylation of lysine 382 on p53, as
determined by the two detection methods (Fig. 5C and D). No
p53 acetylation was detected with ING2 protein alone. There-
fore, ING2 enhances p300-induced p53 acetylation in vitro.
ING2 expression level regulates the switch between senes-
cence and proliferation. To investigate how ING2 has a direct
effect on replicative senescence, we took two approaches to
altering endogenous ING2 protein levels. First, we overex-
pressed ING2 in PDL28 MRC5 fibroblasts, using an ING2-
expressing retrovirus, and analyzed the occurrence of prema-
ture senescence by the SA--Gal assay. ING2 overexpression
induced premature senescence in PDL28 fibroblasts (Fig. 6A
to C). However, ING2 overexpression-mediated induction of
senescence was not observed in isogenic MRC5 cells in which
p53 had been inactivated by a small interfering RNA (siRNA)
retroviral construct (Fig. 6B and C). These results confirmed
and extended our earlier observation that the presence of
functional p53 is required for the growth-suppressive functions
of ING2 (35).
Based on the above results, we hypothesized that if overex-
pression of ING2 promoted senescence, expression knock-
down of ING2 could induce cell growth in senescent cells.
Presenescent late-passage MRC5 fibroblasts (PDL59) were in-
fected with retroviral constructs containing p53 siRNA or
ING2 siRNA and cultured for 3 weeks. The number of result-
ant colonies was then counted. Immunofluorescence and
Western analysis indicated that ING2 expression was effec-
tively down-regulated by the ING2 siRNAs tested (Fig. 6D and
E). Moreover, ING2 knockdown led to a decrease in p53
acetylation on lysine 382 (Fig. 6E), consistent with the possi-
bility that ING2 may play a role in the induction of p53 acet-
ylation during replicative senescence. As expected, the down-
regulation of p53 expression resulted in an enhancement of
colony formation (Fig. 6F). The number of both small (10 to 50
cells, about four to five doublings) and large (50 cells; 5
doublings) colonies was increased. Interestingly, the down-
regulation of ING2 resulted in a statistically significant in-
crease only in the number of small colonies (containing 10 to
50 cells). Thus, suppression of ING2 expression results in an
extension of the life span of human fibroblasts for a limited
number of divisions.
DISCUSSION
We have previously demonstrated that ING2 is a DNA dam-
age-inducible gene that negatively regulates cell proliferation
through the activation of p53 by enhancing its acetylation (35).
In this communication, using a combination of biochemical
and cell biological assays, we have demonstrated that ING2 is
also a component of the p53-mediated replicative senescence
pathway. ING2 expression levels modulate the onset of p53-
dependent replicative senescence in primary normal human
fibroblasts (Fig. 6). This role of ING2 is possibly specific to
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replicative senescence and not PML-mediated ras-induced se-
nescence, because ING2 levels are not altered after ras expres-
sion and ras can induce premature senescence in fibroblasts in
which ING2 has been knocked down (Fig. 2). We demonstrate
that during replicative senescence, ING2 colocalized with post-
translationally modified p53 and p300 (Fig. 3). ING2 also en-
hanced the binding of p53 to p300, and acted as a cofactor for
p300-mediated p53 (lysine 382) acetylation (Fig. 4F and 5).
While the interaction between p53 and ING2 may be either
direct or indirect, our results indicate that both the above
proteins interacted with p300 in an in vivo physiological pro-
cess, replicative senescence. Hence, these results implicate
ING2 as a member of the p53-driven replicative senescence
pathway and suggest that ING2, p300, and posttranslationally
modified p53 play a major role in regulating senescence. How-
ever, compared with cells in which p53 is knocked down, the
delay of senescence, due to ING2 knockdown, is limited to
only a few additional population doublings (three to five). This
may be due to redundancy between the ING proteins. Indeed,
ING1 has also been implicated in replicative senescence (20).
Replicative senescence can be bypassed by p53 inactivation,
which can occur by antibody microinjection and by the over-
expression of p53 dominant-negative mutants, viral oncopro-
teins, antisense oligonucleotides, or siRNAs (5, 8, 22, 52). p53
inactivation results in an additional 10 to 20 cell divisions
before reaching a crisis caused by telomere attrition (9). Dur-
ing replicative senescence, the transcriptional activity of p53 is
increased, which in turn results in the enhanced expression of
p21 and ultimately leads to the cellular senescence phenotype
(3, 7, 50). p53 activation occurs through changes in its phos-
phorylation and acetylation status (2, 11, 24, 42). When p53 is
activated during replicative senescence, phosphorylation on
residues serine 15 and threonine 18 increases, whereas it de-
creases on serine 392 (53). Similarly, p53 acetylation on lysines
320 and 382 increases the p53 transactivation function, possibly
as a result of acetylation-induced conformational changes (31,
34, 42). p53 phosphorylation on serine 15 has been directly
correlated with p21 transcription in replicative senescent fibro-
blasts (29). Incidentally, we found that other known p53 target
genes (like the WIG1 and PERP genes) were transcriptionally
activated during replicative senescence (data not shown). Con-
firming these previous results, we observed that p53-serine 15
phosphorylation and p53-lysine 382 acetylation were increased
during replicative senescence in MRC5 fibroblasts (Fig. 3).
The mechanistic role of p53 acetylation in replicative senes-
cence remains to be determined.
We have previously reported that ING2 overexpression en-
hances p53 acetylation on lysine 382, thereby activating p53
and allowing the cells to undergo apoptosis (35). ING2 can
enhance p53 acetylation by positively modulating the activity of
acetyltransferase complexes. PCAF, CBP, and p300 are the
known coactivators of p53 and potentiate its transcriptional
activity, as well as its biological function, in vivo by recruiting
and acetylating the p53 C-terminal domain (24). Hence, p300-
deficient cells fail to fully acetylate p53 and do not transacti-
vate p21 or undergo G1/S arrest after UV irradiation (30). It
must be noted that for immunofluorescence studies, because of
the prelysis used prior to the fixation of cells, the pattern of
expression of insoluble proteins does not necessarily reflect the
overall amount of protein contained in cells as observed by
Western blot analysis. Here, we have demonstrated that p300
(but not CBP) played an essential role with ING2 during rep-
licative senescence (Fig. 4; see Fig. S2 in the supplemental
material). Mechanistically, we show that the acetylation func-
FIG. 5. ING2 enhances p300-induced p53 acetylation. (A and B) p300 acetylated p53 on lysine 382 in vitro. p53 was incubated with increasing
amounts of p300 (5 to 20 ng) either in a cold reaction (A) or in the presence of 14C-labeled acetyl-CoA (B). The p53 acetylation (Lys382) was
detected either by probing with p53 (Lys382) antibody (A) or by autoradiography (B). The overall amount of p53 protein was monitored by probing
with p53 (DO-1) (A) or by Coomassie blue staining (B). The quantification of 14C incorporation was assessed with a PhosphorImager. (C and D)
ING2 enhances p300-induced p53 acetylation on lysine 382 in vitro. p53 acetylation on lysine 382 was detected by Western blotting. Increasing
amounts of ING2 (10, 20, and 40 ng) were incubated with a constant amount of p300 (5 ng) either in a cold reaction (C) or in the presence of
14C-labeled acetyl-CoA (D). p53 acetylation (Lys382) was detected either by probing with p53 (Lys382) antibody (C) or by autoradiography (D).
The overall amount of p53 protein was monitored by probing with p53 (DO-1) (C) or by Comassie blue staining (D). The quantification of 14C
incorporation was assessed using a PhosphorImager.
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tion of p300 on p53 was enhanced by ING2 in vitro (Fig. 5).
Therefore, we propose that the cofactor function of ING2 on
p300-dependent p53 acetylation may have a major impact dur-
ing a physiological process such as senescence.
In a previous study using transfected p53 and ING2 alleles in
cancer cell lines, p53 did not interact with ING2 (35). Here, we
conclusively demonstrate that during senescence, ING2 and
p53 were part of the same complex with p300 (Fig. 4). We,
therefore, speculate that the interaction between p53 and
ING2 may not only depend on physiological context, but may
also be governed by different posttranslational modifications
that are not necessarily recapitulated during a transient trans-
fection experiment.
So, how does ING2 modulate p53 function during replica-
tive senescence? The increase in ING2-p53-p300 colocaliza-
tion during senescence probably results in ING2-mediated en-
hanced physical interaction between p53 and p300 (Fig. 4F),
leading to the increased acetylation of the tumor suppressor.
Other mutually nonexclusive possibilities regarding the effect
of ING2 on p300 also exist. For example, direct interaction
between ING2 and p300 can alter p300 conformation and
facilitate p53 acetylation. ING2 may also be involved in regu-
FIG. 6. ING2 levels modulate replicative senescence in fibroblasts. (A) ING2 overexpression in young fibroblasts induced premature senes-
cence. Young fibroblasts were infected with an empty retrovirus (control) or a retrovirus containing ING2. Senescence was detected by SA--Gal.
(B) Effect of ING2 on replicative senescence depended on p53. The quantitation of the results shown in panel A and a parallel experiment done
with MRC5 p53 siRNA was carried out. The graphs represent means  SD. At least 300 cells were counted for each experiment. (C) Levels of
ING2 and p53 during induction of senescence in normal human and p53-deficient fibroblasts. ING2 expression in young fibroblasts infected with
empty retrovirus or retrovirus containing ING2 (left) or p53 protein expression in fibroblasts infected with a retrovirus containing a scrambled
siRNA or p53 siRNA (right). Cell lysates were probed with antibodies against ING2 (rabbit), p53 (DO-1), and -actin. (D) Loss of ING2 in
near-senescence fibroblasts leads to its reduced detection by immunofluorescence. MRC5 fibroblasts were infected with retrovirus containing two
different ING2 siRNAs and selected. After infection, fibroblasts were fixed, and immunofluorescence was carried out with antibodies against ING2
(goat). DNA was stained by DAPI (4,6-diamidino-2-phenylindole). (E) The expression knockdown of ING2 leads to a decrease in p53 (Lys382)
acetylation but not p53 detected with DO-1 in MRC5 fibroblasts infected with a retrovirus containing ING2 siRNA. After selection, cells were
lysed, and lysates were probed with antibodies against ING2 (rabbit), p53 (Lys382), and -actin. (F) The down-regulation of ING2 stimulates cell
proliferation. ING2 or p53 siRNAs were retrovirally infected in MRC5 fibroblasts. After selection, cells were trypsinized and counted, and the same
number of cells was seeded in flasks for each experiment. Three weeks later, cells were fixed with formaldehyde and stained with crystal violet.
Colonies with 10 to 50 cells or with 50 cells were counted. The experiments were done in triplicate. The graphs represent means  SD.
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lating deacetylase complexes and may prevent the access of
deacetylases to p300 and/or p53. Indeed, ING1b can directly
interact with SIRT1 and thus enhance p53 acetylation (32). It
is also possible that ING2 has some effect on the previously
reported E3 ubiquitination activity of p300 (25). The p300-
ING2-p53 complex may bind to promoters of genes, because
p53 DNA binding activity increases in senescent cells (3). This
complex may also be localized on telomeres or in a novel
senescence-specific subnuclear body.
p53 has been previously shown to be involved in ras-induced
senescence (41). During ras-induced senescence, an increased
amount of p53 was detected within PML nuclear bodies (NBs),
which colocalized with CBP. In the absence of PML, p53 acet-
ylation on lysine 382 was reduced and cells did not undergo
senescence (41). By contrast, in replicative senescence, only a
small fraction of ING2 colocalized in PML NBs in both young
and replicative senescent fibroblasts (Fig. 2). Moreover, very
little ING2 colocalization was observed with CBP. Instead,
enhanced colocalization was observed with the CBP homolog,
p300 (Fig. 4; see Fig. S2 in the supplemental material). The
complex formed by ING2, p300, and phospho-p53 (Ser15)
colocalized outside the PML NBs (data not shown). Interest-
ingly, in contrast to replicative senescence, during ras-induced
senescence the level of ING2 decreased and overexpression of
ras was able to induce premature senescence with the same
efficiency in cells in which ING2 was knocked-down (Fig. 2).
Thus, ras-induced senescence and replicative senescence may
have divergent cellular signatures, and ING2 does not play a
significant role in ras-induced senescence. Notably, ras-induced
senescence relied on p14/p19ARF-dependent activation of
p53, whereas replicative senescence relies on the activation of
stress and checkpoint kinases. ING2, thus, appears to play a
specific role in augmenting one signaling pathway and not the
other, possibly due to its specific role in promoting p53 acet-
ylation that occurs after ATM and Chk2 phosphorylation.
Though p53 and p16 are two major tumor suppressors that
govern the senescence process, other auxiliary factors such as
ING2 may also help to fine-tune the process and allow it to
proceed to its logical end point. Hence, the loss of factors such
as ING2 does not have as dramatic an effect as the loss of p53
on cellular proliferation. The challenge that remains is deci-
phering how signal transduction is processed from the telo-
meres to factors like ING2, so that they can function during
replicative senescence. It has been demonstrated that p53
phosphorylation is modulated by pathways involving ATM,
ATR, Chk1, and Chk2 proteins—all of which are activated by
uncapped telomeres (13, 29, 43, 48). Apart from their role in
signal transduction, Chk1 and Chk2 have also been implicated
recently in replicative senescence (13, 21). It is tempting to
speculate that these DNA perturbation-sensing proteins may
functionally interact with ING2 and that such interactions may
affect their mutual functions in a temporal manner. The rela-
tive effects of these auxiliary factors may become more appar-
ent with the availability of ING2 gene knockout mice and mice
generated from an intercross with p53 knockout mice.
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